Patent · US Active

Tetrahydroisoquinoline derivatives

US10105359B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

UCB BIOPHARMA SRL · BE

Inventors

Anne Valade · Brussels, BE
Eric Jnoff · Brussels, BE
Ali Ates · Marbais, BE
Pierre Burssens · Brussels, BE
David Skolc · Brussels, BE
Zara Sands · Brussels, BE
Benoit Mathieu · Brussels, BE

Key dates

Filing date	Oct 6, 2015
Grant date	Oct 23, 2018
Priority date	—
Expiry date	Oct 6, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.